Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
AIMS Bioengineering is Scopus-indexed (Q3, CiteScore 2.5), WoS ESCI. Published by American Institute of Mathematical Sciences.
Checked against the index lists dated .
ISSN 2375-1495Verify ISSN ↗
Publisher: American Institute of Mathematical Sciences
Cost to publish: About US$300 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Engineering (miscellaneous) | 153 / 300 | 49th | Q3 |
| Biotechnology | 215 / 325 | 34th | Q3 |
| Biomedical Engineering | 233 / 342 | 32nd | Q3 |
| Bioengineering | 135 / 168 | 19th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q3, CiteScore 2.5.
AIMS Bioengineering is Q3 in Engineering (miscellaneous) (rank 153 of 300), Q3 in Biotechnology (rank 215 of 325) and Q3 in Biomedical Engineering (rank 233 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
AIMS Bioengineering is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.5, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.300, quartile Q3, with an H-index of 7.
The publisher lists an article processing charge of about US$300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
AIMS Bioengineering is published by American Institute of Mathematical Sciences. Its ISSN is 2375-1495.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
AIMS Bioengineering has an h-index of 32 and a 2-year mean of 3.01 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q3. On 2-year citations it ranks #84 of 268 Scopus journals in Engineering (miscellaneous).
AIMS Bioengineering published 28 papers in 2025; its busiest recent year was 2020 with 29. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2023–2026), authors are most often from India (19%), China (17%) and Brazil (9.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.